把供应商、客户、政府合同、重大协议、项目与产能做成逐条可核验的关系账本。 每条边都保留方向、证据等级、原文、日期和官方链接，不把“属于同一产业链”当成真实供销关系。
| 关系方向 | 关系 / 状态 | 金额 / 产能 | 证据 | 披露日期 | 详情 |
|---|---|---|---|---|---|
Adaptive Biotechnologies CorporationADPT National Institutes of Health ADAPTIVE BIOTECHNOLOGIES CORPORATION:1186779 [24-013767] | 政府合同 已完成 置信度 98% | $234.9K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $234,900 from National Institutes of Health. ADAPTIVE BIOTECHNOLOGIES CORPORATION:1186779 [24-013767] |
结构化政府合同或两端官方记录；金额与合同编号可回到原始记录核验。
SEC、公司 IR 或 EIA 正式材料点名对手方、项目或设施；方向不明确时单独标注。
海关、提单等物流信号只能作为线索，不单独写成已确认供销事实。
| 2026-07-30 |
| 核验证据 |
Adaptive Biotechnologies CorporationADPT Department of Veterans Affairs CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS | 政府合同 已完成 置信度 98% | $95.0K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $95,000 from Department of Veterans Affairs. CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT National Institutes of Health COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT | 政府合同 已完成 置信度 98% | $308.4K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $308,400 from National Institutes of Health. COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT Defense Health Agency CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER | 政府合同 已完成 置信度 98% | $385.9K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $385,920 from Defense Health Agency. CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $243.8K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $243,750 from Department of Veterans Affairs. CLONO-SEQ TESTING. USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT Department of the Army CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES | 政府合同 进行中 置信度 98% | $245.7K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $245,700 from Department of the Army. CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES USAspending.gov | 2026-07-30 | 核验证据 |